Cite
HARVARD Citation
Sakamoto, K. et al. (2017). BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides. Journal of clinical pharmacology. pp. 1460-1471. [Online].